NCT07623980 Dusting vs Fragmentation Laser Cystolithotripsy for Pediatric Bladder Stones
| NCT ID | NCT07623980 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beni-Suef University |
| Condition | Bladder Calculi |
| Study Type | INTERVENTIONAL |
| Enrollment | 110 participants |
| Start Date | 2026-05-06 |
| Primary Completion | 2027-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 110 participants in total. It began in 2026-05-06 with a primary completion date of 2027-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Bladder stones are a clinically relevant pediatric urological condition that may require endoscopic treatment. Transurethral Holmium:YAG laser cystolithotripsy is a minimally invasive option for selected children with bladder stones. This prospective randomized trial will compare two Holmium:YAG laser strategies during transurethral cystolithotripsy in children with a single bladder stone less than 3 cm: dusting and fragmentation. Children will be randomized to undergo laser dusting or laser fragmentation during transurethral cystolithotripsy. The primary outcome is total operative time. Secondary outcomes include laser time, need for active fragment extraction, endoscopic stone-free status at the end of the procedure, ultrasound-assessed stone-free status during follow-up, intraoperative complications, postoperative urinary symptoms, urinary tract infection, need for postoperative catheterization, and hospital stay.
Eligibility Criteria
Inclusion Criteria: 1. Children aged less than 18 years. 2. Radiologically confirmed single bladder stone less than 3 cm. 3. Suitable for transurethral cystolithotripsy. 4. Fit for general anesthesia. 5. Written informed consent from parents or legal guardians. Exclusion Criteria: 1. Giant bladder stones more than 3 cm. 2. Urethral pathology preventing safe transurethral access. 3. Major lower urinary tract anomaly or neurogenic bladder. 4. Active untreated urinary tract infection. 5. Coagulation disorder or contraindication to endoscopic surgery.
Contact & Investigator
Hany F Badawy, MD
PRINCIPAL INVESTIGATOR
Faculty of Medicine, Beni-Suef University hospital
Frequently Asked Questions
Who can join the NCT07623980 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying Bladder Calculi. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07623980 currently recruiting?
Yes, NCT07623980 is actively recruiting participants. Contact the research team at Hanyfathy86@gmail.com for enrollment information.
Where is the NCT07623980 trial being conducted?
This trial is being conducted at Banī Suwayf, Egypt.
Who is sponsoring the NCT07623980 clinical trial?
NCT07623980 is sponsored by Beni-Suef University. The principal investigator is Hany F Badawy, MD at Faculty of Medicine, Beni-Suef University hospital. The trial plans to enroll 110 participants.